A multi-institutional study reports an effective treatment approach to inhibit and keep latent viruses like herpes simplex from reactivating and causing disease. The work, whose lead author is the late James Hill, PhD, LSU Health New Orleans Professor and Director of Pharmacology and Infectious Disease at the LSU Eye Center, is published in the December 3, 2014, issue of Science Translational Medicine.
The research team, led by Thomas M. Kristie, PhD, Chief of the Molecular Genetics Section in the National Institute of Allergy and Infectious Diseases' Laboratory of Viral Diseases, and also included Timothy Foster, PhD, LSU Health New Orleans Associate Professor of Microbiology, Immunology & Parasitology, studied herpes simplex virus (HSV) infection in several animal models.
They found that an existing drug, tranylcypromine (TCP), blocked a protein called LSD1, which plays a major role in the initiation of herpes simplex virus infection. Current treatments require active viral replication and target late stages of infection, which has led to the development of drug resistance. This study took a different approach - targeting a drug to a protein that controls how genes are turned on and off, early in the viral replication process.
This "epigenetic" approach not only reduced symptoms, but unlike existing treatments, also reduced shedding (the release of virus particles which can transmit the virus even in the absence of symptoms) and forced the virus to remain in a latent stage, preventing its reactivation. Results indicate that even when a virus is not active, drugs modulating epigenetic changes can still treat the infection. Researchers have been pursuing epigenetic-based therapies for cancer, and this study demonstrates its potential as effective antiviral therapy, too.
A high percentage of the human population is infected with the herpes simplex virus and carries the virus in a latent state. After the initial infection, HSV typically goes dormant in cells where it remains. It can then reactivate with a recurrence of symptoms. Even when latent, asymptomatic shedding of the virus continues its transmission.
Neonatal HSV infections can result in death or developmental-neurological issues. HSV eye infections and recurrences are the leading viral cause of infectious blindness or the need for corneal transplants. In addition, along with other herpesviruses, HSV is a complicating factor in immunosuppressed individuals and is a cofactor in HIV transmission.
Although he died before the study was published, LSU Health New Orleans professor Dr. James M. Hill participated in the research. "Dr. Hill was a distinguished and respected herpesvirologist/animal model scientist who passed away approximately a year ago," notes Dr. Foster. "He is lead author on this manuscript due to both his contributions to the work and out of honor and respect for his contributions to the field and all of us involved."
In addition to researchers from the National Institutes of Health and LSU Health New Orleans, scientists from the Food and Drug Administration, Harvard Medical School, Cincinnati Children's
Hospital Medical Center and the University of Alabama Birmingham also participated. The research was supported by grants from the National Institute of Allergy and
Infectious Diseases, National Eye Institute, Research to Prevent Blindness Senior Investigator Award, LSU Health Sciences Center New Orleans, the Louisiana Lions Eye Foundation and U.S. Food and Drug Administration Intramural Funding.
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's health university leader, LSU Health New Orleans includes a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region.
In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSU Health New Orleans research enterprise generates jobs and enormous economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu , http://www.twitter.com/LSUHealthNO , or http://www.facebook.com/LSUHSC .
Leslie Capo | EurekAlert!
Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington
New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.
New Manufacturing Technologies for New Products
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
22.06.2017 | Physics and Astronomy
22.06.2017 | Physics and Astronomy
22.06.2017 | Materials Sciences